z-logo
open-access-imgOpen Access
Mitigation of gastrointestinal graft-<i>versus</i>-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination
Author(s) -
Saurabh Chhabra,
Anikó Szabó,
Annelie Clurman,
Katelynn McShane,
Nicholas R. Waters,
Daniel Eastwood,
Lisa Samanas,
Fei Teng,
Gabriel K Armijo,
Sameen Abedin,
Walter L. Longo,
Parameswaran Hari,
Mehdi Hamadani,
Nirav N. Shah,
Lyndsey Runaas,
James H. Jerkins,
Marcel van den Brink,
Jonathan U. Peled,
William R. Drobyski
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2022.281309
Subject(s) - tocilizumab , medicine , diversity (politics) , gastroenterology , biology , disease , political science , law

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here